Delivery Order SPE2DB24D2010-SPE2DB24FZVM0
Award Date
6/24/24
Potential Completion Date
6/25/24
Potential Value
$2.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of VYVANSE 40 mg capsules to the Defense Logistics Agency (DLA), a defense agency. The contract, valued at $1,649.20, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a firm fixed price with a completion date of December 17, 2024. This appears to be a delivery order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, valued at...
This federal contract award is for the delivery of VYVANSE 50 MG CAPSULE 100S to the Defense Logistics Agency (DLA), with a ceiling value of $1,617.28. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, and is a Delivery Order under an Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of...
This federal contract award is for the delivery of VYVANSE 20 MG CAPSULE 100S to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, and has a ceiling value of $2,809.24. The contract is a delivery order with a firm fixed price pricing type and an ultimate completion date of June 3, 2024. The contract was not designated with any set-aside requirements, indicating...
This federal contract award is for the delivery of VYVANSE 40 MG CAPSULE 100S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, and has a ceiling value of $3,482.01. It is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as...
This federal contract award is for the delivery of VYVANSE 60 MG CAPSULE 100S, a pharmaceutical product, to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on September 17, 2024, with a ceiling value of $1,724.00 and a completion date of September 18, 2024. This is a delivery order contract with a firm fixed price pricing type. The contract is not designated with a...
This federal contract award is for the supply of VYVANSE 40 MG CAPSULE 100S, a pharmaceutical product, to the Defense Logistics Agency (DLA), a defense agency under the U.S. Department of Defense. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, and has a ceiling value of $2,169.80. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, valued at up to $999,999,999.00 through December...
This federal contract award is for the delivery of VYVANSE 70 MG CAPSULE 100S to the Defense Logistics Agency (DLA). The $1,927.45 firm fixed price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on January 24, 2025, with an ultimate completion date of January 27, 2025. The contract is not designated as a set-aside procurement. Amerisourcebergen Drug Corp holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that...
This federal contract award is for the delivery of VYVANSE 60 MG CAPSULE 100S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on March 17, 2025, with a ceiling value of $2,047.22 and a completion date of March 18, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at...
This federal contract award is for the delivery of 4,564,801 units of VYVANSE 40 MG CAPSULE 100S to the Defense Logistics Agency (DLA). The $7,082.18 firm fixed-price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order under a larger indefinite delivery contract (IDC) valued at $999,999,999 held by Amerisourcebergen with the DLA Troop Support Medical through November 2026. This IDC serves as a...
This federal contract award is for the delivery of VYVANSE 40 MG CAPSULE 100S to the Defense Logistics Agency (DLA), a defense agency of the U.S. Department of Defense (DoD). The contract was awarded to the Corporate Office division of Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on June 26, 2024 with a ceiling value of $1,382.60. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is June 27, 2024. This award is not...